XNYS · PHR
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Phreesia, Inc.

Phreesia, Inc.

SERVICES-BUSINESS SERVICES, NEC
$10.94

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is PHR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Phreesia, Inc.
SERVICES-BUSINESS SERVICES, NEC
Listed since
2019
Employees
2K
Country
US

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$10.94
Last session
Day high
$10.94
Last session
Day low
$10.94
Last session
Previous close
$10.94
52W high
$10.94
0.00% from high
52W low
$10.94
Market cap
$676.2M
EPS
$-0.2600
Shares out
61.8M
VWAP
$10.94
Last session
Veridion warehouse edge

Warehouse intelligence for PHR.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

PHR insider activity

Phreesia, Inc.

Score
Coverage building
Pressure
Net buying
Filings
120
Buys / sells
36 / 84
Net value
$20.6M
Insiders
16
Named filers
EL
Egbuonu-Davis Lisa
Insider
Leadership
MG
Munson Gillian
Insider
Leadership
KJ
Kessler Jon
Insider
Leadership
Cluster

7 insiders bought in the last 90 days

Net pressure

Net buying: $20.6M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-262026-06-25Egbuonu-Davis LisaInsidersell$9.532,54638,316$24KSEC Form 4
2026-06-262026-06-24Munson GillianInsiderbuy$9.5919,29066,104$185KSEC Form 4
2026-06-262026-06-24Egbuonu-Davis LisaInsiderbuy$9.5919,29040,862$185KSEC Form 4
2026-06-262026-06-24Kessler JonInsiderbuy$9.5919,29043,884$185KSEC Form 4
2026-06-262026-06-24Sayar RaminInsiderbuy$9.5919,29052,725$185KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 115 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

PHR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PHR in this window.
Lobbying spend

PHR lobbying filings, year to date.

Registered lobbying filings matched to Phreesia, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PHR in this window.
Latest news · PHR
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for PHR.
Options
Sovereign unlock shows live options positioning for PHR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.